ATE339426T1 - Arylborsäuren für die behandlung von fettsucht - Google Patents

Arylborsäuren für die behandlung von fettsucht

Info

Publication number
ATE339426T1
ATE339426T1 AT02746808T AT02746808T ATE339426T1 AT E339426 T1 ATE339426 T1 AT E339426T1 AT 02746808 T AT02746808 T AT 02746808T AT 02746808 T AT02746808 T AT 02746808T AT E339426 T1 ATE339426 T1 AT E339426T1
Authority
AT
Austria
Prior art keywords
sub
substituted
sup
group
optionally
Prior art date
Application number
AT02746808T
Other languages
German (de)
English (en)
Inventor
Stephen Randall Holmes-Farley
W Harry Mandeville Iii
Chad Cori Huval
Xinhua Li
Pradeep K Dhal
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ATE339426T1 publication Critical patent/ATE339426T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02746808T 2001-06-29 2002-07-01 Arylborsäuren für die behandlung von fettsucht ATE339426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30208101P 2001-06-29 2001-06-29
US35946702P 2002-02-22 2002-02-22

Publications (1)

Publication Number Publication Date
ATE339426T1 true ATE339426T1 (de) 2006-10-15

Family

ID=26972758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02746808T ATE339426T1 (de) 2001-06-29 2002-07-01 Arylborsäuren für die behandlung von fettsucht

Country Status (12)

Country Link
US (3) US6858592B2 (https=)
EP (1) EP1404685B1 (https=)
JP (1) JP2004535452A (https=)
AT (1) ATE339426T1 (https=)
AU (2) AU2002316499B2 (https=)
CA (1) CA2489681A1 (https=)
CY (1) CY1105829T1 (https=)
DE (1) DE60214713T2 (https=)
DK (1) DK1404685T3 (https=)
ES (1) ES2275888T3 (https=)
PT (1) PT1404685E (https=)
WO (1) WO2003002570A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US6858592B2 (en) * 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
AU2003223930A1 (en) * 2002-06-14 2003-12-31 Novo Nordisk A/S Pharmaceutical use of boronic acids and esters thereof
AU2003291567A1 (en) * 2002-11-19 2004-06-15 Genzyme Corporation Polymeric boronic acid derivatives as lipase inhibitors
KR20070086076A (ko) * 2004-11-12 2007-08-27 트러스티즈 오브 터프츠 칼리지 리파아제 억제제
EP1867650B1 (en) * 2005-03-14 2012-06-27 Eisai R&D Management Co., Ltd. Hydroxymethylboron compounds
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
US10157355B2 (en) 2005-11-15 2018-12-18 General Electric Company Method to view schedule interdependencies and provide proactive clinical process decision support in day view form
US7801058B2 (en) * 2006-07-27 2010-09-21 Mobitrum Corporation Method and system for dynamic information exchange on mesh network devices
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
WO2009012596A1 (en) * 2007-07-24 2009-01-29 The University Of British Columbia Substituted aryl-fluoroborates as imaging agents
CA2721060A1 (en) * 2008-04-09 2009-10-15 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118155A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8709489B2 (en) 2009-09-30 2014-04-29 Surmodics, Inc. Emulsions containing arylboronic acids and medical articles made therefrom
RU2015143910A (ru) 2010-02-03 2018-12-28 Инфинити Фармасьютикалз, Инк. Ингибиторы амид-гидролазы жирных кислот
US8546617B1 (en) 2012-03-23 2013-10-01 Empire Technology Development Llc Dioxaborinanes and uses thereof
IN2015DN00805A (https=) * 2012-07-31 2015-07-03 Empire Technology Dev Llc
US9120938B2 (en) 2012-07-31 2015-09-01 Empire Technology Development Llc Polymerizable organoboron alkyd resin anti fouling coatings
ES2618374T3 (es) * 2012-10-17 2017-06-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Composiciones y métodos para mejorar la absorción de glucosa
WO2014134716A1 (en) 2013-03-08 2014-09-12 The University Of British Columbia Substituted organofluoroborates as imaging agents
EP3362462B1 (en) 2015-10-12 2021-07-21 Advanced Cell Diagnostics, Inc. In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
CN106243343B (zh) * 2016-08-11 2018-04-03 江苏大学 一种苯硼酸功能化嵌段聚合物的合成及应用
US12427209B2 (en) 2018-12-18 2025-09-30 Provincial Health Services Authority Dual mode 18F-labelled theranostic compounds and uses thereof
TW202304469A (zh) * 2021-03-24 2023-02-01 美商杜夫特學院信託管理公司 酸化合物、組合物及方法

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496722A (en) 1981-05-01 1985-01-29 The Children's Medical Center Corporation Reporter compounds
GB8819224D0 (en) 1988-08-12 1988-09-14 Merck Patent Gmbh Process for preparation of rod-like compounds
DE3930663C1 (en) 1989-09-14 1990-11-15 Merck Patent Gmbh, 6100 Darmstadt, De Cross-coupling metal organic cpds. and e.g. halogen cpds. - includes using transition metal-palladium catalyst and opt. metal alcoholate
EP0478050A1 (en) 1990-09-24 1992-04-01 Unilever N.V. Detergent composition
GB9024775D0 (en) 1990-11-14 1991-01-02 Axis Research Chemical compounds
IE914573A1 (en) 1991-01-17 1992-07-29 Ici Plc Boron compounds
DE69206795T2 (de) 1991-04-30 1996-09-05 Procter & Gamble ARYLBORONSäURE ENTHALTENDE FLüSSIGWASCHMITTEL
GB9119920D0 (en) 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
CH683522A5 (de) 1992-03-13 1994-03-31 Hoffmann La Roche Verfahren zur Herstellung von Diarylen.
JP3257029B2 (ja) 1992-04-22 2002-02-18 日本油脂株式会社 フェニルボロン酸誘導体及び製造方法
CA2096496A1 (en) 1992-05-29 1993-11-30 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
US5290817A (en) 1992-06-09 1994-03-01 The Du Pont Merck Pharmaceutical Co. Substituted 1-benzylindanes and their use as inhibitors of phospholipase A2
DE69330069D1 (en) 1992-12-21 2001-05-03 Syngenta Ltd Chinuclidin derivate als squalen synthase inhibitoren
GB2276162A (en) 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benazilide derivatives
JP3894949B2 (ja) 1993-06-30 2007-03-22 ザ、ウェルカム、ファンデーション、リミテッド 抗アテローム性動脈硬化症ジアリール化合物
WO1995002046A1 (en) 1993-07-09 1995-01-19 Novo Nordisk A/S Boronic acid or borinic acid derivatives as enzyme stabilizers
JP3412198B2 (ja) * 1993-08-31 2003-06-03 日本油脂株式会社 変性マレイン酸共重合体および用途
WO1995011243A1 (en) 1993-10-19 1995-04-27 Smithkline Beecham Plc Benzanilide derivatives as 5ht-1d receptor antagonists
JPH09508373A (ja) 1994-01-27 1997-08-26 チバーガイギー アクチェンゲゼルシャフト パラジウム触媒による交差カップリング反応を経由するアリール酢酸エステル誘導体の製造方法
US5631364A (en) 1994-03-31 1997-05-20 Axis Biochemicals Asa Labelled boronic acid derivatives
SI9400289A (en) 1994-07-13 1996-02-29 Ponikvar Jadranka Buturovic A method for preventing blood coagulation in a haemodialysis circuit or haemodialysis analogy procedure in the extra-body circuit.
WO1996017833A1 (en) 1994-12-09 1996-06-13 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
WO1996021716A1 (en) 1995-01-09 1996-07-18 Novo Nordisk A/S Stabilization of liquid enzyme compositions
AU5147196A (en) 1995-03-27 1996-10-16 Smithkline Beecham Plc Bicyclic amine derivatives and their use as anti-psychotic a gents
UA58494C2 (uk) 1995-06-07 2003-08-15 Зенека Лімітед Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
DE69621131T2 (de) 1995-06-13 2002-11-28 Novozymes A/S, Bagsvaerd 4-substituierte-phenylboronsäuren als enzymstabilisatoren
US5631371A (en) 1995-11-22 1997-05-20 Bayer Corporation Method for the preparation of substituted 3-(phenylimino)-3H-phenothiazines and phenoxazines
GB9603137D0 (en) 1996-02-15 1996-04-17 Merck Sharp & Dohme Therapeutic agents
WO1998022820A1 (en) 1996-11-21 1998-05-28 Lawrence Livermore National Laboratory Detection of biological molecules using boronate-based chemical amplification and optical sensors
EP0975614A1 (en) 1997-04-18 2000-02-02 Smithkline Beecham Plc A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
US6184363B1 (en) 1997-06-13 2001-02-06 Northwestern University Inhibitors of β-lactamases and uses therefor
AU8140898A (en) 1997-06-13 1998-12-30 Northwestern University Inhibitors of beta-lactamases and uses therefor
EP1000031A4 (en) 1997-07-25 2001-08-16 Smithkline Beecham Corp VITRONECTIN RECEPTOR ANTAGONISTS
CO5011067A1 (es) 1997-11-03 2001-02-28 Novartis Ag Derivados de bifenilo como productos farmaceuticos, su pre- paracion y composiciones farmaceuticas que los contienen
US6264937B1 (en) 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
CA2321791A1 (en) 1998-03-18 1999-09-23 Ciba Specialty Chemicals Holding Inc. Coupling reactions with palladium catalysts
AU5235599A (en) 1998-07-31 2000-02-21 Eli Lilly And Company N-substituted sulfonamide derivatives
DE69919179T2 (de) 1998-09-09 2005-07-28 Inflazyme Pharmaceuticals, Ltd., Richmond Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
GB9824310D0 (en) 1998-11-05 1998-12-30 Univ London Activators of soluble guanylate cyclase
GB9824579D0 (en) 1998-11-10 1999-01-06 Novartis Ag Organic compounds
DE19857765A1 (de) 1998-12-15 2000-06-21 Clariant Gmbh Verfahren zur Herstellung von para-Oxadiazolyl-phenyl-boronsäuren
WO2000035904A1 (en) 1998-12-16 2000-06-22 Northwestern University INHIBITORS OF β-LACTAMASES AND USES THEREFOR
WO2000042213A1 (en) 1999-01-13 2000-07-20 The Research Foundation Of State University Of New York A novel method for designing protein kinase inhibitors
BRPI0011172B8 (pt) 1999-04-14 2021-05-25 Pacific Corp derivados do 4,5-diaril-3(2h)-furanona como inibidores de ciclooxigenase-2
JP4507294B2 (ja) 1999-05-27 2010-07-21 チッソ株式会社 ビアリール誘導体の製造方法
CA2315614C (en) 1999-07-29 2004-11-02 Pfizer Inc. Pyrazoles
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
EP1889891B1 (en) 2000-11-30 2017-11-22 Canon Kabushiki Kaisha Luminescence device and display apparatus
JP3589450B2 (ja) 2001-03-13 2004-11-17 独立行政法人 科学技術振興機構 アミド脱水縮合触媒として有用なパーフルオロアルキルフェニルホウ酸
US6858592B2 (en) * 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
AU2003243594A1 (en) 2002-06-13 2003-12-31 Johns Hopkins University Novel boronic chalcone derivatives and uses thereof
US7045652B2 (en) * 2002-07-03 2006-05-16 Pfizer Inc Processes for preparing substituted aryl boronic acids

Also Published As

Publication number Publication date
WO2003002570A1 (en) 2003-01-09
ES2275888T3 (es) 2007-06-16
US7456156B2 (en) 2008-11-25
US20030064963A1 (en) 2003-04-03
DE60214713D1 (de) 2006-10-26
CA2489681A1 (en) 2003-01-09
US20060128664A1 (en) 2006-06-15
US7049304B2 (en) 2006-05-23
JP2004535452A (ja) 2004-11-25
CY1105829T1 (el) 2011-02-02
EP1404685B1 (en) 2006-09-13
AU2002316499B2 (en) 2005-08-04
US6858592B2 (en) 2005-02-22
AU2005220192A1 (en) 2005-12-01
PT1404685E (pt) 2007-01-31
HK1065046A1 (en) 2005-02-08
DK1404685T3 (da) 2007-01-22
EP1404685A1 (en) 2004-04-07
US20050107336A1 (en) 2005-05-19
DE60214713T2 (de) 2007-09-06

Similar Documents

Publication Publication Date Title
ATE339426T1 (de) Arylborsäuren für die behandlung von fettsucht
CA2462085A1 (en) Cytotoxic agents
CA2426885A1 (en) Complexes of phosphate derivatives
KR940003969A (ko) 피이지(peg)- 인터페론 결합체
EP0394989A3 (en) Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same
KR920012108A (ko) 담즙산 유도체, 이의 제조방법 및 약제로서의 이의 용도
EP2253330A3 (en) Conjugated biological molecules and their preparation
RU2004127136A (ru) Способ получения гамма-амидов глутамовой кислоты
CA2448319A1 (en) Cytotoxins, prodrugs, linkers and stabilizers useful therefor
KR927003520A (ko) 펩티딜(peptidyl) 유도체
PT77110B (fr) Procede de preparation de nouveaux derives de la xanthine
DE3769676D1 (de) Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
KR870003130A (ko) 테이코플라닌 화합물의 아미드
ES484167A1 (es) Un procedimiento para preparar 9-(hidroxialcohil)-purinas
KR890005035A (ko) 벤조일아미노페녹시부탄산 유도체와 그의 제조방법 및 이를 포함하는 제약조성물
EP0345723A3 (en) Diethylenetriamine pentaacetic acid derivatives
DE69529624D1 (de) Neue endiyn-chinonimine und verfahren zu deren herstellung und verwendung
JP2002524523A5 (https=)
EA200100969A1 (ru) Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции
JP2004534887A5 (https=)
CA2452920A1 (en) Benzo [g] quinoline derivatives for treating glaucoma and myopia
EP1264833A3 (en) 1,2-Phenylenediboronic acid reagents and complexes
KR910014344A (ko) 베타-치환 술폰산 및/또는 술포네이트 및 그의 제조방법
BR9400847A (pt) Compostos e processo para sua preparação, medicamentos e composições farmacêuticas
ES2182396T3 (es) Procedimiento para la obtencion de acidos grasos dimeros, alcoxilados.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1404685

Country of ref document: EP

REN Ceased due to non-payment of the annual fee